Source-grounded facts extracted from Trulieve Cannabis Corp.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Trulieve Cannabis Corp. reported first quarter ended March 31, 2026 results: revenue $287 million, net income $2 million.
“as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation • First quarter revenue of $287 million, with 59% gross margin • Positive net income of $2 million and Adjusted EBITDA of $100 million* • Rescheduling of medical marijuana to Schedule III enabled applications for DEA”
Trulieve Cannabis Corp. incurred senior notes of U.S. $60 million aggregate principal amount at 10.5% per annum maturing December 17, 2030.
“On January 29, 2026, Trulieve Cannabis Corp. (the “Company”) issued an additional U.S. $60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Additional Notes”).”
Trulieve Cannabis Corp. entered into Indenture with Odyssey Trust Company valued at U.S. $60 million aggregate principal amount (effective 2026-01-29).
“On January 29, 2026, Trulieve Cannabis Corp. (the “Company”) issued an additional U.S. $60 million aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Additional Notes”).”
Trulieve Cannabis Corp. incurred senior notes of $140,000,000 aggregate principal amount with Odyssey Trust Company at 10.5% maturing December 17, 2030.
“On December 17, 2025, Trulieve Cannabis Corp. (the “Company”) issued $140,000,000 aggregate principal amount of its 10.5% senior secured notes due December 17, 2030 (the “Notes”).”
Ryan Blust was appointed as Interim Chief Financial Officer at Trulieve Cannabis Corp..
“The Company has appointed Ryan Blust, the Company’s Vice President, Finance, as its interim Chief Financial Officer, effective immediately.”
Wes Getman resigned as Chief Financial Officer at Trulieve Cannabis Corp..
“On March 6, 2025, Wes Getman resigned from his position as Chief Financial Officer of Trulieve Cannabis Corp. (the “Company”) to pursue other opportunities.”
Trulieve Cannabis Corp. reported the quarter ended March 31, 2024 results: revenue $298 million, net income net loss of $23 million.
“--- tcnnf-2024xq1xexx991 Exhibit 99.1 Trulieve Reports First Quarter 2024 Results Demonstrating Core Business Strength and Cash Generation • First quarter performance of $298 million in revenue, up 4% sequentially, and 58% gross margin • Strong cash flow from operations of $139 million and free cash flow of $124 million* in Q1 2024 • Definitive progress made”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.